Management of hyperglycemia in acute stroke: How, when, and for whom?

Stroke

Volumn 39, Issue 7, 2008, Pages 2177-2185

  McCormick, Michael T ^a   Muir, Keith W ^a   Gray, Christopher S ^b   Walters, Matthew R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; GLUCOSE; HEPARIN; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; POTASSIUM; SARUPLASE; SOMATOMEDIN RECEPTOR;

ACUTE DISEASE; BLOOD CLOT LYSIS; BLOOD GLUCOSE MONITORING; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIABETES MELLITUS; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG EFFECT; DRUG MEGADOSE; DRUG RECEPTOR BINDING; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; GLUCOSE INFUSION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; LOW DRUG DOSE; MORTALITY; NEUROPROTECTION; NONHUMAN; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; PREVALENCE; PRIORITY JOURNAL; REVIEW; STROKE; STROKE PATIENT; STROKE UNIT; TREATMENT OUTCOME; AGED; BRAIN; DISEASE COURSE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HOSPITAL SUBDIVISIONS AND COMPONENTS; METABOLISM; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY;

AGED; BLOOD GLUCOSE; BRAIN; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; FIBRINOLYSIS; HOSPITAL UNITS; HUMANS; HYPERGLYCEMIA; INSULIN; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); STROKE; TREATMENT OUTCOME;

EID: 47649085123     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.496646     Document Type: Review

References (96)

1. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurol. 2002;59:67-71.
2. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycemia across clinical subtypes of acute stroke. Lancet. 1999;353:376-377.
3. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper-glycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
4. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-28.
5. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. American Heart Association; American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38: 1655-1711.
6. Thomassen L, Brainn M, Demarin V, Grond M, Toni D, Venables GS; EFNS Task Force on Acute Neurological Stroke Care. Acute stroke treatment in Europe: a questionnaire based survey on behalf of the EFNS task force on acute neurological stroke care. Eur J Neurol. 2003;10: 199-204.
7. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol. 1985;42:661-663.
8. Melamed E. Reactive hyperglycemia in patients with acute stroke. J Neurol Sci. 1976;29:267-275.
9. Gray CS, Taylor R, French JM, Alberti KG, Venables GS, James OF, Shaw DA, Cartlidge NE, Bates D. The prognostic value of stress hyper-glycemia and previously unrecognized diabetes in acute stroke. Diabet Med. 1987;4:237-240.
10. Sprafka JM, Virnig BA, Shahar E, McGovern PG. Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: the Minnesota Heart Survey. Diabetic Med. 1994;11:678-684.
11. Woo E, Ma JTC, Robinson JD, Yu YL. Hyperglycemia is a stress response in acute stroke. Stroke. 1988;19:1359 -1364.
12. O'Neill PA, Davis I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke. 1991;22: 842-847.
13. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ. 1997;314:1303-1306.
14. Allport L, Butcher K, Baird T, MacGregor L, Desmond PM, Tress BM, Colman P, Davis SM. Acute stress hyperglycemia is associated with insular cortical ischemia. Stroke. 2004;35:248.
15. Moreton FC, McCormick M, Muir KW. Insular cortex hypoperfusion and acute phase blood glucose after stroke: a CT perfusion study. Stroke. 2007;38:407-410.
16. Oppenheimer SM, Hoffbrand B, Oswald GA, Yudkin JS. Diabetes mellitus and early mortality from stroke. BMJ. 1985;291:1014-1015.
17. Riddle MC, Hart J. Hyperglycemia, recognised and unrecognised, as a risk factor for stroke and transient ischemic attacks. Stroke. 1982;13: 356-359.
18. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyper-glycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208-2214.
19. Sawin CT. Action without benefit. The sliding scale of insulin use. Arch Int Med. 1997;157:489.
20. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Int Med. 2004;164:2005-2011.
21. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myo-cardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
22. Malmberg K. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
23. Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005; 293:437-446.
24. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345: 1359-1367.
25. Van den Berghe G. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
26. Van den Berghe G. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151-3159.
27. Devos P. European glucose control study. www.glucontrol.org. Accessed March 28, 2007.
28. NICE-SUGAR study: http://www.thegeorgeinstitute.org/iih/index.cfm? CBEB61E0-D192-95-F9-9C1E-6A2474B45DCC. Accessed March 10, 2007.
29. Brunkhorst FM. Intensive insulin therapy in patients with severe sepsis and septic shock in associated with an increased rate of hypoglycemia-results from a randomized multicenter study (VISEP). Infection. 2005;33:19.
30. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG; GIST Trialists Collaboration. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).Lancet Neurol. 2007;6:397-406.
31. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurol. 2005;64:1348-1353.
32. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalising blood glucose after acute ischemic stroke. Acad Emerg Med. 2006;13:174-180.
33. Cleland SJ, Petrie JR, Connell JC. Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension. 2000;35:507-511.
34. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363: 768 -774.
35. Fisher M. Characterizing the Target of Acute Stroke Therapy. Stroke. 1997;28:866-872.
36. Walters MR, Weir CJ, Lees K. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycemic acute ischemic stroke patients. Cerebrovasc Dis. 2006;22: 116-122.
37. Bruno A, Saha C, Williams LS, Shankar R. IV insulin during acute cerebral infarction in diabetic patients. Neurol. 2004;62:1441-1442.
38. Johnston KC. Glucose Regulation in Acute Stroke Patients Trial. https:// grasptrial.org/grasp/home.aspx Accessed 2 May 2007.
39. Treatment of hyperglycaemia in ischemic stroke trial. http:// www.strokecenter.org/trials/TrialDetail.aspx?tid=686. Accessed August 28th 2007.
40. Auer RN. Insulin, blood glucose levels, and ischemic brain damage. Neurol. 1998;51:S39-S43.
41. Zhu CZ, Auer RN. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J Cereb Blood Flow Metab. 1994;14: 237-242.
42. Wass CT, Scheithauer BW, Bronk JT, Wilson RM, Lanier WL. Insulin treatment of corticosteroid-associated hyperglycemia and its effect on outcome after forebrain ischemia in rats. Anesthesiology. 1996;84: 644-651.
43. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322:1769-1774.
44. Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycemic control. Diabet Med. 1993;10:27-32.
45. Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogan EL. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurol. 1991;41:899-905.
46. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Normoglycaemia (not Hypoglycaemia) optimises outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metabol. 1994;14:227-236.
47. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. ArchIntern Med. 2004;164:2005-2011.
48. Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg. 2004;101:664-668.
49. Voll CL, Auer RN. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J Cereb Blood Flow Metabol. 1991;11: 1006-1014.
50. Apstein CS, Taegtmeyer H. Glucose-insulin-potassium in acute myocardial infarction. Circulation. 1997;96:1074-1077.
51. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. Elevated circulating free fatty acid levels impair endothelium dependent vasodilatation. J Clin Invest. 1997;100: 1230-1239.
52. Aljada A, Ghanim H, Saadeh R, Dandona P. Insulin inhibits NFkB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinology Metab. 2001;86:450-453.
53. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyo-padhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment- elevation myocardial infarction. Circulation. 2004; 109:849-854.
54. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab. 2000;85:2572-2575.
55. Ferrando AA, Chinckes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999;229:11-18.
56. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyper-glycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurol. 1982;32:1239-1246.
57. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke. 1999;30:160-170.
58. Siemkowicz E, Hansen AJ. Brain extracellular ion composition and EEG activity following 10 minutes ischemia in normo- and hyperglycemic rats. Stroke. 1981;12:236-240.
59. Widmer H, Abiko H, Faden AI, James TL, Weinstein PR. Effects of hyperglycemia on the time course of changes in energy metabolism and pH during global cerebral ischemia and reperfusion in rats: correlation of 1H and 31P NMR spectroscopy with fatty acid and excitatory amino acid levels. J Cereb Blood Flow Metab. 1992;12:456-468.
60. Li PA, Shuaib A, Miyashita H, He QP, Siesjö BK, Warner DS. Hyper-glycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke. 2000;31:183-192.
61. Siesjo BK, Bendek G, Koide T, Westerberg E, Wieloch T. Influence of acidosis on lipid peroxidation in brain tissues in vitro. J Cereb Blood Flow Metab. 1985;5:253-258.
62. OuYang YB, Mellergård P, Kristián T, Kristiánova V, Siesjö BK. Influence of acid-base changes on the intracellular calcium concentration of neurons in primary culture. Exp Brain Res. 1994;101:265-271.
63. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke. 1999;30:160-170.
64. Cronberg T, Rytter A, Asztely F, Söder A, Wieloch T. Glucose but not lactate in combination with acidosis aggravates ischemic neuronal death in vitro. Stroke. 2004;35:753-757.
65. Smith D, Pernet A, Hallett WA, Bingham E, Marsden PK, Amiel SA. Lactate: a preferred fuel for human brain metabolism in vivo. J Cereb Blood Flow Metab. 2003;23:658-664.
66. Gill R, Andine P, Hillered L, Persson L, Hagberg H. The effect of MK-801 on cortical spreading depression-induced calcium transients on neuronal viability in moderatley hypoglycemic rats. J Cereb Blood Flow Metabol. 1992;12:371-379.
67. Hopwood SE, Parkin MC, Bezzina EL, Boutelle MG, Strong AJ. Transient changes in cortical glucose and lactate levels associated with peri-infarct depolarisations studied with rapid sampling microdialysis. J Cereb Blood Flow Metabol. 2005;25:391-401.
68. Strong AJ, Boutelle MG, Vespa PM, Bullock MR, Bhatia R, Hashemi P. Treatment of Critical care Patients with substantial acute ischemic or traumatic brain injury. Crit Care Med. 2005;33:2147-2149.
69. Christensen H, Boysen G. Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur J Neurol. 2002;9:297-301.
70. Allport LE, Baird TA, Butcher KS, Macgregor L, Prosser J, Colman P, Davis S. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care. 2006;29: 1839-1844.
71. Gray CS, Scott JF, French JM, Alberti KG, O'Connell JE. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing. 2004;33:71-77.
72. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper-glycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
73. Cox NH, Lorains JW. The prognostic value of blood glucose and glyco-sylated haemoglobin estimation in patients with stroke. Postgrad Med J. 1986;62:7-10.
74. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med. 1983;74:540-544.
75. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363: 768-774.
76. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE; NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurol. 2002;59:669-674.
77. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, Codina A, Quintana M. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke. 2003;34:1235-1241.
78. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, Huertas R, Santamarina E, Rubiera M. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke. 2004;35:2493-2498.
79. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Mönting J, Schumacher M, Lücking CH. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis. 2002;13:89-94.
80. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, Quintana M, Alvarez-Sabín J. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36:1705-1709.
81. Benz J, Hofmann A. Annexins: from structure to function. Biol Chem. 1997;378:177-183.
82. Martini SR, Hill MD, Alexandrov AV, Molina CA, Kent TA. Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy. Neurol. 2006;67:700-702.
83. Hamilton M, Tranmer B, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg. 1995;82:262-268.
84. Fukuoka S, Yeh H, Mandybur T, Tew J. Effect of insulin on acute experimental cerebral ischemia in gerbils. Stroke. 1989;20:396 -399.
85. Zhao YJ, Yang GY, Domino EF. Acute ethanol effects on focal cerebral ischemia in nonfasted rats. Alcohol Clin Exp Res. 1997;21:745-748.
86. Nedergaard M, Diemer NH. Focal ischemia of the rat brain with special reference to the influence of plasma glucose concentration. Acta Neuropathologica. 1987;73:131-137.
87. Bomont L, MacKenzie ET. Neuroprotection after focal cerebral ischaemia in hyperglycaemic and diabetic rats. Neurosci Lett. 1995;197: 53-56.
88. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metabol. 1991;11:1025-1030.
89. Izumi Y, Pinard E, Roussel S, Seylaz J. Insulin protects brain tissue against focal ischemia in rats. Neurosci Lett. 1992;144:121-123.
90. Kazan S, Karasoy M, Baloglu H, Tuncer R. The effect of mild hypothermia, mannitol and insulin induced hypoglycaemia on ischaemic infarct volume in the early period after permanent middle cerebral artery occlusion in the rat. Acta Neurochir (Wien). 1999;141:979-987.
91. Combs DJ, Dempsey RJ, Kumar S, Donaldson D. Focal cerebral infarction in cats in the presence of hyperglycemia and increased insulin. Metab Brain Dis. 1990;5:169-178.
92. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurol. 1999;52:280 -284.
93. Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, Molinari GF, Frederick LS, Roberts HC, Gebel JM, Sila CA, Schulz GA, Roberts RS, Gent M. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurol. 2001;57: 1603-1610.
94. Martini S, Hill M, Alexandrov A, Molina C, Kent T. Outcome in hyper-glycemic stroke with ultrasound augmented thrombolytic therapy. Neurol. 2006;67:700-702.
95. Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, Munuera J, Alvarez-Sabin J. Hyperglycaemia during ischaemia rapidly accelerates brain damage in stroke patients treated with tPa. J Cereb Blood Flow Metabol. 2007;27:1616-1622.
96. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Monting J, Schumacher M, Lücking CH. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis. 2002;13:89-94.